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Phagocytosis of bacteria by normal neutrophils
depends on glycolysis for its energy supply. After
bacterial uptake by the neutrophils and before
bacterial killing takes place, there is a switch 
in glucose metabolism from anaerobic glycolysis
to the aerobic pentose phosphate pathway, and
intracellular oxygen consumption and H2O2 pro-
duction increase markedly. The metabolic changes
Distinct Differences in the Induction of
Stimulus-mediated Superoxide Generation 
by Polymorphonuclear Neutrophils Isolated
From Patients With Different Types of
Leukemia
Li-Yu Tsai,1 Jai-Nien Tung,2 Tsan-Zon Liu3*
Background/Purpose: Accumulating literature has documented that there exists a distinct difference in
nitro blue tetrazolium reduction capacity by the polymorphonuclear neutrophils (PMNs) from patients
with different types of leukemia. The underlying mechanism associated with this observed phenomenon
remains to be clarified.
Methods: The production of O2−, monitored by a validated probe (lucigenin)-based ultraweak chemilumi-
nescence, in resting and/or phorbol-1,2-myristate-1,3-acetate (PMA)- and zymosan-stimulated systems of
various leukemic PMNs was measured. In parallel with these studies, we also quantified superoxide dismutase
isozymes (Cu, Zn-SOD, Mn-SOD) from these isolated PMNs by established methods.
Results: A marked increase was observed in O2− generation by the PMNs from patients with acute myeloid
leukemia (AML), and chronic myeloid leukemia (CML), but not from patients with acute lymphocytic
leukemia (ALL) when compared with controls either in the resting condition or after being stimulated by
either PMA or zymosan. In parallel, we also quantified SOD isozyme activities and found that the total
and CuZn-SOD of PMNs from AML were indeed significantly lower than either controls or ALL, implying
that higher levels of O2− generation might result from a deficiency in this O2−-metabolizing enzyme.
Conclusion: Our data suggest that a distinct difference in the capability of O2− generation under stimulated
conditions between PMNs from ALL and AML (or CML) may be of potential taxonomic or even therapeutic
usefulness. [J Formos Med Assoc 2008;107(7):513–518]
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ORIGINAL ARTICLE
are normally accompanied by the reduction of
nitro blue tetrazolium (NBT) when this dye is in-
troduced into a system of phagocytosing leuko-
cytes. It has been reported that a proportion of
immature and mature monocytes from patients
with acute monocytic leukemia can reduce NBT.
However, there was a marked difference in NBT
reduction capacity between monocytic and myelo-
blastic leukemia.1
It has been documented that NBT is reduced
by the superoxide anion (O2−) with the formation
of blue formazan.2 Based on this observation, we
hypothesized that the relative difference in the
capability of NBT reduction by various human
leukemic cells might be related to the amount 
of O2− production. Alternatively, it might also be
due to the difference in the content of superoxide
dismutase (SOD), which governs the metabolism
of O2−.
Many different pathways for O2− generation in
neutrophils have been postulated, one of which
depends on phorbol-1,2-myristate-1,3-acetate
(PMA) or diacylglycerol (DG) and calcium iono-
phore, and is inhibited by protein kinase C (PKC)
inhibitors.3,4 Alternatively, a receptor-mediated
O2− generation, such as the opsonized zymosan
(OZ)-stimulated reaction which is insensitive to
PKC inhibitors, but is inhibited by a tyrosine kinase
inhibitor (e.g. genistein) constitutes involvement
of a second pathway.5,6 Recently, PMA or OZ has
been shown to stimulate macrophages to produce
chemiluminescence (CL), originating from either
a respiratory burst or from nitroperoxide formed
by a reaction between nitric oxide (NO) generated
by NO synthase and O2− generated by NAPDH
oxidase. Both O2− and nitroperoxide play an im-
portant role in microbicidal and tumoricidal 
activities and in modulating the signaling and
communication of important information to the
cells.7,8 Thus, the kinetic processes of NO and
oxygen free radical generation in PMA- or OZ-
stimulated macrophages and PMNs in leukemia
can be considered a valuable research area to be
investigated.
A probe-based ultraweak chemiluminescence
(uwCL) technique for the detection of a panel of
four oxygen-derived free radicals including O2−
has recently been developed by us.9 With the avail-
ability of this novel technique, it is possible to
monitor the capability of O2− generation by PMNs
from different types of leukemia. Herein, we report
the findings of this study and the possible mech-
anism associated with the differences observed
between different types of leukemia.
Methods
Patients
Twenty-one patients (12 females, 9 males; mean
age, 37±5 years) including five with acute myeloid
leukemia (AML) at M1 with no maturation, eight
with acute lymphocytic leukemia (ALL) and eight
with chronic myeloid leukemia (CML) in chronic
phases without treatment were recruited for this
study. Four healthy and age-matched subjects were
also included to serve as controls.
The diagnosis of leukemia was made by mor-
phologic and cytochemical studies of bone marrow
smears. The study was approved by the ethics com-
mittee of Kaohsiung Medical University Hospital
and informed consent was obtained from all
participants.
Chemicals
Unless stated otherwise, all chemicals were of an-
alytical quality, and doubly distilled water was used
throughout. PMA, zymosan and lucigenin were
purchased from Sigma Chemical Co. (St. Louis,
MO, USA). EDTA, thiobarbituric acid, NaCN, and
NaCl were purchased from Merck. Activity of
SOD in PMNs was assayed by the commercial
Ransod kit, which was obtained from Randox
Laboratories, UK.
Blood procurement and preparation of PMNs
With informed consent, venous blood samples
were obtained from normal healthy volunteers
and from leukemia patients and placed in heparin
vacutainers. The separation of PMNs was carried
out immediately after blood collection. We re-
moved lymphocytes from whole blood by gradient
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centrifugation with Ficoll-Pague (Amersham Phar-
macia Biotech, Sweden). The PMNs were then
separated from the rest of blood by sedimentation
with 2% dextran in normal saline by the method
described elsewhere.10,11 PMNs were washed by
centrifugation at 250g at 4°C, with normal saline
and finally resuspended in 2 mL of the same buffer.
Contaminating red cells were eliminated using
3.6% NaCl and ice water. A portion of the PMNs
was used for monitoring O2− generation using 
lucigenin-based uwCL. The remainder of the PMNs
was suspended in normal saline and sonicated on
ice in 20-second bursts at 4 output for 2 minutes,
and then the extracts were centrifuged at 50,000g
for 30 minutes at 4°C. Supernatants were then di-
luted with an appropriate buffer and used for assay-
ing total SOD, CuZn-SOD, and Mn-SOD activities.
Protein contents of these supernatants were deter-
mined by the method described by Bradford.12
Measurement of O2
- generation
O2− generation of PMNs from either resting or
stimulated systems (PMA and OZ) was measured
by the probed-based uwCL technique as described
recently by Chen et al.9
Briefly, 0.05 mL of PMNs (1×106 cells/mL) was
mixed with 0.25 mL of 2 mM lucigenin in 0.2 mL
of PBS buffer, pH 7.4. This mixture was put in
the flat-bottomed reaction cuvette and placed 
in the appropriate position in a black-box unit of
the uwCL analyzer with a high sensitivity detector
(3.3 × 10−15 W/cm2 count) (Jye Horn Co., Taipei,
Taiwan). Photon emission from PMNs was
counted at 10-second intervals at 37°C for a total
of 2500 seconds under atmospheric conditions.
Measurement of SOD activity
Activity of SOD in PMNs from peripheral blood
was estimated by the commercial Ransod kit
(Randox Laboratories). The method is based on
the generation of superoxide anions produced by
xanthine and xanthine oxidase, which react with
2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenylte-
trazolium chloride to from a red formazan dye.
SOD activity was measured by the degree of inhibi-
tion of this reaction. For measurement of Mn-SOD
activity, NaCN (5 mM final concentration) was
added 1 hour before measuring SOD activity to
inhibit CuZn-SOD activity.13 Mn-SOD activity was
subtracted from the total SOD activity to calcu-
late the CuZn-SOD activity. Results were expressed
as U/mg protein.
Statistical analysis
All results are expressed as mean ± standard de-
viation. Statistical significance was assessed by
Student’s t test. A p value of less than 0.05 was
considered to be significant.
Results
Figure 1 shows the representative example of O2−
generation as monitored by the lucigenin-based
uwCL, by PMNs derived from two different types
of leukemia in the resting condition and after
stimulation with either PMA or zymosan. Figure 2
shows that uwCL generated by both stimuli were
capable of being inhibited by capsaicin, a quinone
analog and an inhibitor of NADPH oxidase, which
elicited O2− generation in a stimulated condition.
We also validated the assay system using SOD and
found that the uwCL generated could be sup-
pressed by this enzyme (data not shown). This
evidence indicated that uwCL generated during
stimulated conditions was indeed O2−.
Having validated our assay system, we then
proceeded to analyze lucigenin-based uwCL by var-
ious PMNs derived from various types of leukemia
either in the resting- or stimulus-activated (PMA
or zymosan) systems. As shown in Figure 3, only
PMNs derived from AML patients had elevated
O2− generation in the resting stage. Conversely,
PMNs derived from either CML or ALL patients
had depressed O2− generation as compared to the
healthy controls. However, under stimulation by
either PMA or zymosan, varying degrees of re-
sponsiveness ensued. First, although there was a
substantial increase in the production of O2− in
response to both stimuli, PMNs from ALL patients
could only elicit uwCL in amounts that were com-
parable to those from healthy controls. In contrast,
Superoxide radical generation in leukemia
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the ability of PMNs derived from either CML or
AML patients to respond to both stimuli increased
markedly. PMNs from both types of leukemia 
responded to zymosan and PMA equally (p<0.05).
Interestingly, PMNs from AML patients could elicit
uwCL nearly 10-fold greater than PMNs from ei-
ther ALL patients or the healthy controls. Also,
nearly 92% (12/13) of PMNs from either CML
or AML patients responded acutely to zymosan
in eliciting O2− generation. Conversely, only 62%
(5 of 8) of PMNs from ALL patients showed
moderate responsiveness toward zymosan. Taken
together, PMNs derived from ALL patients were
L.Y. Tsai, et al
516 J Formos Med Assoc | 2008 • Vol 107 • No 7
352
264
176
88
0
0 500 1000 1500 2000 2500
+ PMA
+ PMA
C
he
m
ilu
m
in
es
ce
nc
e
Time (sec)
2824
2118
1412
706
0
0 500 1000 1500 2000 2500
C
he
m
ilu
m
in
es
ce
nc
e
Time (sec)
+ Zymosan
+ Zymosan
Resting Resting
352
264
176
88
0
C
he
m
ilu
m
in
es
ce
nc
e
+ PMA
0 500 1000 1500 2000 2500
Time (sec)
+ Zymosan
Resting
A
C
B
Figure 1. A representative diagram showing time-
dependent emission of lucigenin-based uwCL moni-
tored by an ultraweak CL analyzer in either resting 
or stimulated conditions in the presence of PMA or
zymosan by PMNs isolated from: (A) an ALL patient;
(B) an AML patient; (C) a healthy control. Note the
major difference in uwCL emission between the PMNs
derived from the two types of leukemia.
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Figure 3. Comparison of the extent of lucigenin-based uwCL
generated in either the resting or stimulated conditions using
PMA or zymosan by PMNs isolated from the controls and
various types of leukemia. R= resting; +P=PMA-stimulated;
+Z = zymosan-stimulated. Concentration of PMA used =
100ng/mL; concentration of zymosan used=1mg/mL. Each
symbol represents a case. Note that both stimuli increased
the production of lucigenin-based uwCL equally effectively
(p < 0.05).
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Figure 2. A representative example showing time-dependent
emission of lucigenin-based uwCL generated either by PMA
or zymosan-stimulated systems by PMNs isolated from an
AML patient, and its inhibition by capsaicin (8-methyl-N-
vanillyl-6-noneamide), a quinone analog. The concentration
of capsaicin used was 0.3 mmol per assay.
shown to be relatively defective in their respon-
siveness toward both stimuli as compared to
PMNs from either CML or AML patients. To clarify
the above-mentioned phenomenon, we then set
out to analyze the total SOD and CuZn-SOD
isozyme activities in PMNs derived from either
healthy controls or various types of leukemia. 
As shown in Figure 4, total SOD and CuZn-SOD
activities in PMNs derived from AML patients
were significantly lower than those derived from
ALL patients, implying that the former cells were
relatively incapable of metabolizing O2− radicals 
effectively.
Discussion
Under resting conditions, we observed that
PMNs derived from AML, but not CML or ALL,
patients could constitutively generate significant
amounts of lucigenin-based uwCL, indicating
that a substantial quantity of the O2− generated
was due to quinone-dependent NADPH oxidase
activity because the lucigenin-based uwCL could
be suppressed by capsaicin (8-methyl-N-vanillyl-
6-noneamide), a quinone analog (Figure 2). Sun
et al reported that NADPH oxidase of HL-60
(human promyelocytic leukemia origin) cells
was inhibited by capsaicin, but upon induction of
differentiation of the HL-60 cells with DMSO, the
NADPH oxidase activity was much less inhib-
ited.14 Our data thus implied that PMNs from
AML patients were relatively undifferentiated, and
their constitutive generation of nontoxic amounts
of O2− might be required for their own prolifera-
tive purposes. This notion has previously been
suggested.15
To further examine if there was a difference in
the induction of stimulus-mediated O2− produc-
tion, PMA- and zymosan-stimulated systems were
chosen. Two different pathways for the generation
of O2− by neutrophils have been postulated: (1)
NADPH/O2 oxidoreductase activity can be stim-
ulated by PMA or DG and inhibited by PKC in-
hibitors;3,4 (2) receptor-mediated O2− generation
can be stimulated by zymosan and is insensitive
to PKC inhibitors, but can be inhibited by a tyro-
sine kinase inhibitor, such as genistein.5 As indi-
cated in Figure 3, PMNs derived from both AML
and CML patients had higher stimulatory propen-
sity toward PMA, implying that lucigenin-elicited
uwCL was mainly derived from the receptor-
mediated pathway and partially through the PKC-
mediated pathway. These data along with those
reported elsewhere16 clearly demonstrated that
AML patients were under high oxidative stress due
to the excessive production of oxygen free radi-
cals with concomitant downregulation of SOD
Superoxide radical generation in leukemia
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Figure 4. Comparison of (A) total SOD and (B) CuZn-SOD activities in PMNs isolated from normal controls and various
types of leukemia.
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activities. Conversely, the mechanism of zymosan-
mediated production of O2− seemed to be im-
paired in PMNs derived from ALL patients. This
finding is consistent with the observed upregula-
tion of SOD activities (Figure 4). Based on these
data, a comparison of the stimulatory propensity
of PMNs from ALL and AML (or CML) may be of
potential taxonomic or even therapeutic usefulness.
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